Over the past several years we have obtained considerable evidence indicating that adenoviruses-expressing interferon a (Ad-IFNa) can overcome resistance to the IFNa protein itself. Since cancer cells infected with Ad-IFNa also show high perinuclear cytoplasmic IFNa expression, we were interested in whether endoplasmic reticulum (ER) stress and cleavage of caspase 4 could have a major role in Ad-IFNa-produced cancer cell death. Indeed, procaspase 4 was upregulated and cleaved as early as 12 h after Ad-IFNa infection of the cancer cells, which co-localized with IFNa staining and ER tracker. In contrast, immortalized normal human urothelial cells, although exhibiting similar perinuclear IFNa staining, showed no cleaved caspase 4. Caspase 4 cleavage was not blocked by the caspase 8 specific inhibitor zIETD, indicating that caspase 4 activation was independent of caspase 8 activation. Blocking caspase 4 also inhibited activation of caspase 3 in Ad-IFNa containing cells. Finally, the cleaved form of caspase 4 (p10) was detected in Ad-IFNa-positive cancer cells from the urine of a patient following intravesical Ad-IFNa/Syn3 treatment. Therefore, ER stress and activation of caspase 4 appears to be an important mechanism involved in the direct cancer cell death produced by Ad-IFNa and also occurs in the clinical setting.
Introduction
Bladder cancer is the second most common genitourinary malignancy and the fifth leading cause of cancer deaths in American men. Approximately 70-80% of patients with newly diagnosed bladder cancer present with superficial bladder tumors. Although most cases of bladder cancer can be adequately managed with periodic transurethral resection, intravesical Bacillus Calmette-Guerin therapy and surveillance, this treatment is far from optimal since B50% of superficial tumors recur after transurethral resection and Bacillus Calmette-Guerin therapy and up to 30% evolve into more aggressive, potentially lethal cancers. Clearly, more effective therapies are necessary to improve overall survival and provide an alternative to radical cystectomy.
We, in collaboration with others, have well documented that prolonged, high concentrations of interferon a (IFNa) occur after Ad-IFNa exposure in both cell culture and in vivo after intravesical instillation of AdIFNa/Syn3. 1, 2 Preclinical studies also showed considerable potential for intravesical treatment with Ad-IFNa in the presence of Syn3 as an excipient for superficial bladder cancer. 1, 2 In addition, it has been documented that Ad-IFNa has unique cytotoxic properties distinct from those of the IFNa protein and that Ad-IFNa can overcome resistance to IFNa itself. [1] [2] [3] [4] This latter finding could be quite important because many human bladder and other cancer cell lines have been shown to be resistant to the IFNa protein, 5 and therefore, one might assume that there will be different levels of sensitivity for the IFNa-produced cell death in various tumors. In addition, Ad-IFNa has little or no cytotoxicity to normal cells.
These studies have lead to a phase 1 trial with intravesical Ad-IFNa/Syn3 for Bacillus Calmette-Guerin refractory superficial bladder cancer, which has recently been completed. 6 However, the molecular mechanisms by which Ad-IFNa kills cancer cells resistant to the IFNa protein itself needs further study and is a high priority for our ongoing research. We have shown that there are two major cytotoxic effects in cancer cells that are resistant to the IFN protein. 7 The first involves a strong bystander effect and the second is associated with Ad-IFNa infection, subsequent high levels of intracellular IFNa produced and the resultant accumulation within the endoplasmic reticulum (ER)-Golgi network. The second cause of cell death is the focus of our present study.
We initially noted that various cancer cell types infected with Ad-IFNa produced high perinuclear cytoplasmic IFNa expression. 1, 3 Since the ER is also localized in this region and caspase 4 is an ER-resident caspase known to be implicated in ER stress-induced apoptosis, it became of interest to determine if ER stress and resultant caspase 4 activation occurred after Ad-IFNa treatment. This in turn could have a major role in the direct effect of Ad-IFNa-produced cancer cell death in Ad-IFNa-resistant cells. ER stress leads to caspase activation through various mechanisms triggering an evolutionarily conserved series of signal-transduction events, which constitutes the unfolded protein response. Although these signaling events aim to ameliorate the accumulation of unfolded proteins in the ER when these events are severe or protracted they can induce cell death.
We report that caspase 4 cleavage is a very early marker of Ad-IFNa-induced ER stress and when inhibited by caspase 4 targeted RNA interference (RNAi) downstream activation of caspase 3 is blocked. In contrast, no caspase 4 cleavage occurred after Ad-IFNa infection of normal urothelial cells. Moreover, cleaved caspase 4 and perinuclear IFNa were seen in tumor cells from the urine following intravesical Ad-IFNa/Syn3 treatment. 6 
Materials and methods

Cell lines
The bladder cancer cell line, UM-UC9, was provided by Dr Barton Grossman. The KU7 cell line was also obtained from Dr Grossman, who originally received the cells from Dr M Tachibana, Keio University, Japan, 8 and were used for some of our experiments. The KU7 cell line was initially thought to be a bladder cancer cell line, but recent mapping results from cells obtained from Japan and stocks we had available have shown the cells to be HeLa. Therefore, they will be referred to as HeLa cells hereafter. This recent finding, however, did not affect any results or conclusions reached but rather extend them to other cell types. The UM-UC9 and HeLa cell lines were grown in MEM and RPMI 1640, respectively, in 10% fetal bovine serum and incubated at 37 1C in 5% CO 2 and 95% air. The telomerase immortalized normal urothelial cell line (TERT-NHUC) was provided by Dr Margaret Knowles and grown in K-SFM medium with cholera toxin. 9 Reagents and adenovirus infection Ad-IFNa2b (Ad-IFNa) was obtained from Merck (formerly Canji/Schering-Plough, Kenilworth, NJ). Cells were exposed to the adenoviral vector at a 50 or 100 multiplicity of infection (50-100 MOI) for 3 h in medium without serum. The virus was then removed and complete medium was added. Transfection frequency was checked by Ad-IFNa staining in order to insure that the transfection rates were comparable in different experiments. Intron A was obtained from ScheringPlough Corporation.
Western blotting
The cancer cells were transfected with a 50-100 MOI of Ad-IFNa. Occasionally, the cells were treated with 25 mM of the caspase 8 specific inhibitor zIETDfmk purchased from Enzyme Systems Products (Livermore, CA). Cells that were still attached at each time point were lysed in sodium dodecyl sulfate buffer (150 mmol/l NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mmol/l Tris (pH 8.0)) and protease inhibitors subjected to 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blotted with the following antibodies: cleaved caspase 3, cleaved caspase 8 and cleaved caspase 9 (Cell Signaling Technology, Beverly, MA) and caspase 4 (Abcam, Cambridge, MA). Equal loading was confirmed by blotting with anti-b-actin antibody (Sigma, St Louis, MO). The blots were incubated with chemiluminescent substrate (Amersham, Piscataway, NJ) and then developed by exposure to X-ray film.
Immunochemical analysis
For IFN studies, immunochemistry was done according to the previously described methods. 1 Briefly, cancer cells were seeded on cover-slips in six-well plate and treated with Ad-IFNa. Forty-eight hours following infection, the cells were fixed with 4% formalin and treated with 0.3% hydrogen peroxide in absolute methanol for 30 min to block endogenous peroxidase activity, followed by antigen retrieval. Cells were incubated overnight with rabbit polyclonal antibody against human IFNa at a 1:500 dilution (PBL, Piscataway, NJ) and then stained using the Vector ABC Elite Kit protocol.
Confocal microscopy analysis for active caspase 4, caspase 3, IFNa and ER localization At various times after infection, the cells were fixed in icecold methanol, blocked in phosphate-buffered saline with 10% normal donkey serum and incubated overnight with a polyclonal sheep antibody against IFNa (PBL diluted 1:1000 in phosphate-buffered saline with 1% donkey serum, with polyclonal goat antibody against cleaved caspase 4 (Santa Cruz Biotechnology, Santa Cruz, CA), diluted 1:500, and monoclonal antibody against KDEL/ Grp78 (Stressgen, Ann Arbor, MI) for ER tracking, diluted 1:200. In some experiments, a polyclonal rabbit antibody against cleaved caspase 3 was used for caspase 3 staining (Cell Signaling Technology).
Cells were washed three times in phosphate-buffered saline, then incubated for 1 h with an Alexa-546-labeled donkey anti-mouse antibody, Alexa-488-labeled donkey anti-rabbit antibody and Alexa-647-labeled donkey antigoat antibody (Molecular Probes, Eugene, OR), as well as the DNA dye DAPI (Molecular Probes) or Topro3 (Invitrogen, San Diego, CA). Digital micrographs were acquired using serial laser excitation on a Leica TCS SP5 laser scanning confocal microscope, and then were imported into a computer for processing using the Leica Application Suite Microscope Software. In order to get rid of the background noise, signal thresholds were set up according to the corresponding control slides. Selected images are representative of at least 10 microscopic fields analyzed for each condition.
Silencing of caspase 4 with an RNAi
A human caspase 4 RNAi (5 0 ac aaccgcaact gcctcagtct gaa3 0 ) and non-targeting universal control RNAi were purchased from Invitrogen. Transfections were performed using Lipofectamine RNAiMax (Invitrogen,) according to the manufacturer's instructions. Silencing of caspase 4 was evaluated by real-time reverse transcriptase-PCR and western blotting comparing samples transfected with a non-targeting universal control and caspase 4 targeting RNAi.
Collection of cells from urine
Briefly, 20 ml of urine from a patient treated 7 days previously with intravesical Ad-IFN/Syn3 6 was pelleted by centrifugation at 400 g for 10 min and the supernatant was discarded. The cell pellet was re-suspended in 1 ml of normal saline and cells were deposited on poly-L-lysinecoated microscope slides using a cytospin centrifuge. Slides were air-dried for 1 h, fixed with acetone briefly and then stored at 4 1C. Hematoxylin-eosin staining was performed to identify bladder cancer cells in the patient's urine samples. In addition, immunofluorescent staining was carried out as described as above to examine the expression of IFNa and whether evidence of cleaved caspase 4 was present using confocal microscopy.
Results
Caspase 4 is cleaved in IFNa protein resistant cancer cells following Ad-INFa treatment but not normal urothelial cells and is an early molecular event of apoptosis mediated by Ad-IFNa Cancer cells infected with Ad-IFNa show high perinuclear cytoplasmic IFNa expression and led to our examination of whether ER stress could have a major role in Ad-IFNa-produced cell death in such cancer cells. Because caspase 4 is an ER-resident caspase known to be implicated in ER stress-induced apoptosis, we decided to investigate whether or not caspase 4 is activated following the Ad-INFa treatment. By western analysis, the activation of caspase 4 was clearly detected in the IFNa-resistant UC9 bladder cancer cells (Figure 1a ) and cervical cancer HeLa cells but not normal urothelial cells (Figure 1b ) 48 h after Ad-INFa treatment using a specific antibody, which recognizes both the large unit (p20) and small unit (p10) of cleaved caspase 4 as well as the procaspase 4.
There are several mechanisms involved in Ad-IFNainduced bladder cancer cell death. 6 First, both normal and bladder cancer cells produce high and prolonged levels of IFNa after Ad-IFNa transfection and expression. If the cancer cells are sensitive to IFNa, they will undergo an apoptotic cell death, largely through a TRAIL (tumor necrosis factor, apoptosis-inducing ligand)-related, caspase-8-dependent mechanism. If the cancer cells are resistant to IFNa, they could be killed by either bystander factors or direct cytotoxicity caused by the high levels of Ad-IFNa produced. In order to define whether caspase 4 activation was involved only in cells showing high perinuclear IFNa levels or bystander produced cytotoxicity as well, we examined the effects of Ad-IFNa on caspase 4 processing by immunofluorescence staining and confocal microscopy using both UC9 and HeLa cells. The cleaved caspase 4 small subunit p10 that was only found in Ad-IFNa-expressing cells (Figure 2a ) indicated that ER stress-induced apoptosis and activation of caspase 4 might be the mechanism involved only in the direct cytotoxicity caused by Ad-INFa and that the bystander effect of Ad-INFa could be triggered by other unknown pathway(s), which is currently under investigation in our laboratory. In addition, both Ad-INFa and activated caspase 4 were found to be co-localized with the enhanced ER signals Ad
shown by using ER tracker, KDEL (Grp78, Grp94), a retrieval motif essential for the precise sorting of KDEL proteins along the secretory pathway, which perform critical functions in the ER related to protein folding as well as assembly (Figure 2a ). Our previous study showed that the proteolytic processing of caspases 3, 8 and 9 occurred after Ad-IFNa treatment in cancer cells. 3 These observations were extended by directly assessing the proteolytic processing of caspase 4 over time following Ad-IFNa treatment. As shown in Figure 2b , p10 initially appeared in the Ad-IFNa-transfected cells at 12 h after Ad-IFNa treatment, whereas caspase 3 was not proteolytically processed at the same time point, indicating that caspase 4 activation could be an early molecular event of apoptosis mediated by Ad-IFNa. Caspase 3 was activated subsequently 28 h after Ad-IFNa treatment and this active form of caspase 3 was detected in both Ad-IFNaexpressing and non-expressing cells by immunofluorescent confocal microscopy (Figure 2b ), consistent with our previous studies on caspase 3 activation, which showed that both direct infection of Ad-IFNa and the bystander factors produced caused caspase 3 activation. 1, 3, 4 Western analysis also indicated that proteolytic processing of caspases 4 appeared as early as 12 h after Ad-IFNa treatment, with activation of caspases 3 and 9 occurring at The small subunit p10 of caspase 4 (green) was detected in the Ad-IFNa-transfected cells (red) 12 h after Ad-IFNa infection, whereas caspases 3 was not activated at the same time point. At 24 h after Ad-IFNa treatment, both cleaved caspase 4 (green) and caspase 3 (blue) forms were stained. The active form of caspase 3 was detected in both Ad-IFNa-expressing (solid arrow) and non-expressing cells (dashed arrow), whereas caspase 4 was only seen in IFNa-expressing cells. This indicates that caspase 4 was activated only in cells which were infected with Ad-IFNa whereas caspase 3 was activated by both Ad-IFNa infection and bystander factors. Nuclei were counterstained with DAPI (gray-white). HeLa cells are shown in this experiment but similar results were seen in UC9 cells. Original magnification Â 400.
B28 h after Ad-IFNa infection ( Figure 3 ). The caspase 4 and caspase 3 results were consistent with the results obtained by confocal analysis (Figure 2b ).
Confocal analysis shows caspase 4 activation is independent of caspase 8 activation in cancer cells and is not present in normal urothelial cells after Ad-IFNa infection
To define the role of caspase 8 in the proteolytic processing of caspase 4, we added the specific inhibitor zIETDfmk to completely block caspase 8 at the concentration and conditions used in our laboratory. As shown in Figure 4a , p10 was still detected at 48 h after Ad-INFa treatment in the presence of zIETDfmk, indicating that the inhibitor had little or no effect on the activation of caspase 4 and that Ad-IFNa-mediated apoptosis occurs via a mechanism that was independent of caspase 8 activation. Parallel western immunoblotting experiments confirmed that the inhibitor completely blocked TRAILinduced caspase 8 activation at the concentrations employed (data not shown).
We previously reported that Ad-IFNa was cytotoxic to cancer cell lines, whereas it was not cytotoxic to normal urothelium. 4 As shown in Figure 4b , Ad-IFNa infection did not induce the activation of caspase 4 in normal urothelial cells, consistent with the western blot results (Figure 1b) . No detectable cleaved caspase 4 was found even though the urothelial cell line hTERT-NHUC had similar adenoviral infection efficiency and Ad-IFNainfected normal urothelial cells showed similar high amounts of perinuclear IFNa expression.
Caspase 4 activation was confirmed in exfoliated bladder cancer cells in voided urine from a patient undergoing intravesical Ad-IFNa/Syn3 treatment An intravesical phase l study using Ad-IFNa has recently been completed for superficial bladder cancer. 6 Based on the results obtained, we thought it could be informative to examine the status of caspase 4 in exfoliated bladder cancer cells in voided urine from a patient in this clinical trial. Urine was collected from this patient 7 days after receiving intravesical Ad-IFNa treatment and the exfoliated bladder cancer cells were examined by immunofluorescent confocal microscopy. Although the number of cancer cells were few, those that were found in the urine displayed coincident caspase 4 activation and Ad-IFNa expression (Figure 4c ). These results supported our cell culture studies and extended them to the clinical setting.
Inhibition of caspase 4 by caspase 4 targeting RNAi blocks early caspase 3 activation
Finding early activation of caspase 4 followed by the activation of caspase 3 suggested that there may be a direct relationship between the two. In order to examine this more closely, caspase 4 activation was blocked by caspase 4 targeted RNAi addition before Ad-IFNa infection. The conditions to block caspase 4 were initially optimized and confirmed by western blotting and real-time reverse transcriptase-PCR (data not shown). We examined the 48-h time point after Ad-IFNa infection since no caspase 3 was activated at the 24-h time point as shown by both western blotting and confocal analysis. In addition, because considerable cytotoxicity also occurs at the 48-h time point as a result of the bystander effect, which in turn produces caspase 3 activation, 3 we were only interested in examining the cells that contained INFa. The basis for this approach is the fact that cells that are killed by the bystander effect do not show any perinuclear IFN staining and the cells that have perinuclear IFN staining as a reflection of direct Ad-IFN transfer also show co-localization of caspase 4 activation (see Figure 4) . Therefore, we could use confocal analysis to determine if blockage of caspase 4 activation in cells, which showed perinuclear IFN staining, also blocked caspase 3 activation. Indeed, we found that in cells showing perinuclear IFN staining in which caspase 4 activation had been blocked by the addition of the caspase 4 targeted RNAi that caspase 3 activation was also inhibited. An example is shown in Figure 5 . However, this was the result seen in all cases where caspase 4 had been inhibited by the addition of caspase 4 targeted RNAi. These findings strongly suggest that the rapid activation of caspase 4 is not only an early signal of ER stress but is also a marker of subsequent cell death produced by Ad-IFNa infection.
Discussion
Ad-IFNa shows a significant potential for the treatment of superficial bladder cancer. 1, 2, 6 Although bladder cancer Figure 3 Upregulation and activation of caspase 4 mediated by Ad-IFNa measured at different time points in UC9 and compared with activation of caspases 3 and 9. The cells were harvested for western analyses using antibodies against caspase 4 active cleaved fragment (MrB20 000 and MrB10 000) and the procaspase 4 (MrB46 000), which were shown as indicated. The same blot was stripped and reprobed with antibody against the active caspase 3 (MrB17 000) and caspase 9 (MrB37 000) forms. b-Actin was used as a control for equal loading. Caspase 4 activation was seen as early as 12-18 h after Ad-IFNa infection, whereas caspase 3 and caspase 9 occurred only 28 h after Ad-IFNa infection. Procaspase 4 also increased over time.
Ad-IFNa-produced ER stress and caspase 4 activation Z Yang et al cells sensitive to recombinant human IFNa are often killed through a TRAIL-related pathway, our previous studies showed that intravesical administration using Ad-IFNa in the presence of the excipient, Syn3, also produced a marked regression of superficial human bladder tumors derived from IFNa-resistant cancer cells. 1, 2 In addition, we have previously documented that Ad-IFNa produces a strong bystander effect in cancer . Activated caspase 4 (p10) (red) was seen in Ad-IFNa (green)-transfected HeLa cells, whereas it was not detectable in the Ad-IFNa-transfected TERT-NHUC cells at the same time point (bottom). The nuclei were counterstained with Topro 3 (blue). (c) The active form of caspase 4 (p10) was detected in exfoliated bladder cancer cells in voided urine from a patient undergoing intravesical Ad-IFNa treatment. 6 A urine sample was collected from a patient 7 days after receiving Ad-IFNa/Syn3 treatment and centrifuged briefly. The exfoliated cells were smeared on slides and fixed instantly with acetone. Cleaved caspase 4 (p10) (green) was clearly detected in IFNa (red) containing bladder cancer cells. The nuclei were counterstained with Topro 3 (blue). Original magnification Â 400.
Ad-IFNa-produced ER stress and caspase 4 activation Z Yang et al cells. 3, 4 These results implied that Ad-IFNa can have highly important additional mechanisms of cell kill in addition to the high levels of IFNa produced. We are presently attempting to obtain the exact identification of these bystander factors.
In our present study, we have centered on the direct cytotoxicity mediated by Ad-IFNa. Although we have already shown that Ad-IFNa induced proteolytic processing of caspases 3, 8 and 9, 3 the molecular background of the anti-tumor effects of Ad-IFNa and the mechanisms of overcoming resistance to the IFNa protein in cancer cells remained undefined. The strong perinuclear IFNa staining, which was seen uniformly following Ad-IFNa treatment to various types of cancer cells 3 and was never observed after exposure to the IFNa protein, led us to examine the possible role of endoplasmic ER stress in the cancer cell death. The accumulation of unfolded proteins in the ER mediates a cellular stress induced by multiple stimuli and pathological conditions. The capacity of the ER to process proteins is limited and the accumulation of unfolded and misfolded proteins, in this case IFNa, can lead to ER stress associated apoptosis.
We have recently reported that ER stress is observed as a direct effect of Ad-IFNa exposure but not by bystander factors. 10 In the present study, we found that caspase 4 activation is a particularly early molecular event following Ad-IFNa transfection and expression of cancer cells. To date, we do not have a complete explanation for the reason that cleaved caspase 4 is detected only in cancer cell lines but not in the normal urothelial cells. A clue to this difference may come from a recent observation. We have found that autophagy is produced after Ad-IFNa treatment of either IFN-resistant cancer cells or the normal urothelial cell line (TERT-NHUC). 11 However, after Ad-IFNa infection autophagosomes, which are an early stage of autophagy, were seen in the cancer cells whereas autophagolysosomes, a later stage of autophagy, were observed mostly in normal cells by electron microscopy. 11 Conditioned medium from either normal or bladder cancer cells, however, produced no autophagy when placed on the bladder cancer cells, although again marked cytotoxicity was observed under these conditions, indicative of bystander factors being produced. 11 This in turn suggested that the autophagy seen after Ad-IFNa infection was related to the direct effect of Ad-IFNa infection and expression rather than to the bystander factors produced.
It was also documented that Ad-IFNa treatment produces the LC3-II autophagic protein form in cancer cells but not normal cells, which in turn was inhibited by the autophagic inhibitor, 3-methyladenine, resulting in a significant increase in apoptotic cell death. We concluded from these findings that the autophagy seen in normal urothelial cells is a protective response and is allowed to be completed, providing a survival mechanism following Ad-IFN treatment, whereas the autophagy produced in IFN-resistant cancer cells is not allowed to be completed and is insufficient to significantly inhibit cytotoxicity. These differences could at least in part be related to the fact that no caspase 4 activation was seen in the normal cells, since the complete autophagy found in normal urothelial cells could protect the cells resulting in a lack of caspase 4 activation. In addition, the fact that inhibition of caspase 4 by caspase 4 siRNA also inhibited the activation of caspase 3 in cells containing high perinuclear IFNa ( Figure 5 ) suggests that the activation of caspase 4 not only is an early marker of ER stress but also signals downstream activation of caspase 3, which in turn is an effector of subsequent cell death. Finally, we have been able to examine cancer cells in the urine from a patient 7 days after intravesical Ad-INFa/ Syn3 treatment. Although few tumor cells were found, all of the cancer cells having IFNa also showed activated caspase 4 by confocal analysis (Figure 4c) . Numerous tumor cells with high IFNa were seen in the superficial bladder tumors produced in our human tumor mouse model after Ad-IFNa infection. 1 We believe that such high perinuclear IFNa results in ER stress, activating caspase 4 and other ER stress signals, which ultimately leads to tumor cell kill. Identifying tumor cells in the patient's urine after intravesical Ad-INFa/Syn3 treatment, which had both high IFNa and caspase 4 activation, strongly suggests that the results we have reported here from studies done in cell culture may also be quite relevant in the clinical setting, where B50% of the patients with Bacillus Calmette-Guerin refractory superficial bladder cancer have obtained a complete remission after a single intravesical instillation of Ad-INFa/Syn3 in our phase I trial. 6 
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